Media
What a buzzy startup reveals about Britain’s biotech sector
The Economist
News
For interview requests or speaking opportunities, get in touch with our Communications team.
-
-
MediaDoctors Thought They Knew What a Genetic Disease Is. They Were Wrong.The Atlantic
-
PressQuotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directorsby Quotient Therapeutics
-
MediaEurope’s rising biotech stars: 10 startups to watch in 2024Labiotech
-
BlogQuotient Academic Cofounder, Professor Sir Mike Stratton, Awarded Royal Society Medalby Quotient Therapeutics
-
PressFlagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizerby Quotient Therapeutics
-
PressQuotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief Scientific Officerby Quotient Therapeutics
-
MediaHere, There, and Everywhere: Somatic Genomics Uncovers DNA Variants to Inspire Drug DiscoveryGEN Biotechnology
-
MediaThe potential of somatic genomics in drug discovery and development with Jake RubensThe Genetics Podcast
-
PressFlagship Pioneering Unveils Quotient Therapeutics to Create Transformative Medicines Informed by a New Frontier of Geneticsby Quotient Therapeutics
-
MediaFrom somatic mutations to QuotientSanger Institute
-
MediaUS $50m helps Sanger-inspired startup to create transformative medicine suiteBusiness Weekly
-
MediaFlagship launches first UK biotech Quotient with genome sequencing platformFierce Biotech
Subscribe
Get the latest from the Quotient team